WHO TRS (Technical Report Series) 1019, 2019 Annex 5
Guidelines on import procedures for medical products - Annex 5
Background
This document is a revision of the 1996 publication:
• Guidelines on import procedures for pharmaceutical products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations, thirty-fourth report. Geneva: World Health Organization; 1996: Annex 12 (WHO Technical Report Series, No. 863; http://apps.who.int/medicinedocs/documents/s21962en/s21962en.pdf).
Click on the titles below for complete guidelines
TABLE OF CONTENTS
8. Procedures applicable to pharmaceutical starting materials
1. Introduction
1.1 Public health considerations demand that medical products should not be treated in the same way as ordinary commodities. Their manufacture and subsequent handling within the distribution chain, both nationally and internationally, must conform to prescribed standards and be rigorously controlled. These precautions serve to assure that patients receive quality assured medical products, and to prevent the infiltration of substandard and suspected falsified medical products into the supply system.
WHO TRS (Technical Report Series) 1019, 2019 Annex 5: